BONEBRIDGE Bone Conduction Implant in Adults
Status: | Not yet recruiting |
---|---|
Conditions: | Other Indications, Other Indications |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/3/2019 |
Start Date: | April 2019 |
End Date: | July 2020 |
Contact: | MED-EL Corporation |
Email: | research.us@medel.com |
Phone: | 1-888-633-3524 |
Outcomes in Adults With Mixed or Conductive Hearing Loss Implanted With the BONEBRIDGE
Approximately thirty subjects with mixed or conductive hearing loss, meeting FDA‐cleared
candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months
post‐activation to assess safety and effectiveness of the BONEBRIDGE implant.
candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months
post‐activation to assess safety and effectiveness of the BONEBRIDGE implant.
Inclusion Criteria:
- Adults, 18 years of age or older at the time of implantation
- Conductive or mixed hearing loss, defined as:
- Conductive hearing loss with pure‐tone average (PTA) for bone conduction thresholds
better than or equal to 25 dB at 500, 1000, 2000 and 3000 Hz
- Mixed hearing loss with PTA for bone conduction thresholds better than or equal to
45dB at 500, 1000, 2000, and 3000 Hz
- Air‐bone gap greater than or equal to 30 dB at 500, 1000, 2000, and 3000 Hz
- Ability to benefit from amplification as defined by a monosyllabic (CNC) word score of
30% correct or better
- Bilateral BONEBRIDGE can be considered if the difference in PTA for bone conduction
thresholds is 10 dB or less between the right and left ears
- Prior experience with acoustic or bone conduction hearing aids, unless candidate is
unable to wear amplification for medical reasons
- Able to complete testing materials in English
- CT scan indicating the patient's anatomy is adequate to enable placement of the
implant
- Ability to undergo general anesthesia
- Appropriate motivation and expectation levels
- Stated willingness to comply with all study procedures for the duration of the study
Exclusion Criteria:
- Evidence that hearing loss is retrocochlear in origin
- Skin or scalp condition precluding use of external audio processor
- Suspected cognitive impairment or organic brain dysfunction
We found this trial at
3
sites
3400 Spruce St
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-4000
Phone: 215-662-2777
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
Click here to add this to my saved trials
Click here to add this to my saved trials
Vanderbilt University Vanderbilt offers undergraduate programs in the liberal arts and sciences, engineering, music, education...
Click here to add this to my saved trials